Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive–compulsive disorder, mini-review and pilot open-label trial
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective: 1 Hz repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area has been shown to be effective in a subset of obsessive–compulsive disorder (OCD) subjects, yet these results are still to be confirmed. This preliminary study compares the efficacy of augmentation with 1 Hz rTMS over the supplementary motor area and the usual augmentation treatment (TAU; treated as usual) with antipsychotics in a sample of selective serotonin reuptake inhibitor (SSRI)-refractory OCD patients. Method: Fifty SSRI-refractory OCD patients consecutively admitted were studied: 25 were treated with a three-week trial of 1Hz, bilateral rTMS over the supplementary motor area and 25 with antipsychotic drugs. Yale–Brown Obsessive–Compulsive Scale (Y-BOCS; primary outcome measure), Hamilton Depression and Hamilton Anxiety scales were administered at first, second and third week of treatment. Results: Y-BOCS showed a statistically significant time effect from the baseline to the third week, with a 68% of responders (Y-BOCS score reduction of ⩾ 25%), in comparison with 24.0% in the TAU group. In the rTMS group, 17.6% of patients achieved remission. Conclusions: 1 Hz rTMS over the supplementary motor area appeared to be effective in approximately 2/3 of SSRI-refractory OCD subjects, whereas in the TAU group only 1/4 of subjects were responders. The supplementary motor area might be a new target area to be further explored with neuromodulation for OCD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Self-citationObsessive-compulsive disorder: beyond segregated cortico-striatal pathways
Milad, M. R., & Rauch, S. L. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.003 · Cited by 847 · cited 2×
“The clinical and physiopathological phenotypes of OCD have been associated with cortico-striato-thalamo-cortical (CSTC) circuitries that subserve motivation and reward-aversion, emotional learning and goal-directed action (Ahmari et al., 2013; Anticevic et al., 2014; Burguiere et al., 2013; Dougherty et al., 2010; Mil…”
BackgroundObsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Repeated cortico-striatal stimulation generates persistent OCD-like behavior
Ahmari, S. E., Spellman, T., Douglass, N. L., Kheirbek, M. A., Simpson, H. B., Deisseroth, K., Gordon, J. A., & Hen, R. (2013) · Science · doi:10.1126/science.1234733 · Cited by 502 · cited 1×
“…with cortico-striato-thalamo-cortical (CSTC) circuitries that subserve motivation and reward-aversion, emotional learning and goal-directed action (Ahmari et al., 2013; Anticevic et al., 2014; Burguiere et al., 2013; Dougherty et al., 2010; Milad and Rauch, 2012; Pauls et al., 2014; Posner et…”
Backgroundde Wit, S. J., de Vries, F. E., van der Werf, Y. D., Cath, D. C., Heslenfeld, D. J., Veltman, E. M., van Balkom, A. J. L. M., Veltman, D. J., & van den Heuvel, O. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010073 · Cited by 303
Mantovani, A., Simpson, H. B., Fallon, B. A., Rossi, S., & Lisanby, S. H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990435 · Cited by 281 · cited 3×
“Although some may argue that the lack of a sham treatment arm cannot exclude a placebo response, data from Mantovani et al. (2010) showed that low frequency rTMS delivered to the SMA may determine more responders among patients who received active treatment than among those who received sham…”
BackgroundMethodResultSimpson, H. B., Foa, E. B., Liebowitz, M. R., Huppert, J. D., Cahill, S., Maher, M. J., McLean, C. P., Bender, J., Marcus, S. M., Williams, M. T., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1932 · Cited by 248 · cited 1×
“A recent study (Simpson et al., 2013) showed the superiority of CBT versus risperidone for augmenting SSRIs in OCD: an intriguing direction for future research could be a comparison between rTMS, CBT and risperidone augmentation in SSRI-refractory OCD.”
Berlim, M. T., Neufeld, N. H., & Van den Eynde, F. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.022 · Cited by 219
Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000740 · Cited by 211 · cited 2×
“Risperidone, which is considered in recent meta-analyses (Dold et al., 2013) the only effective augmentation treatment for SSRI-refractory OCD, has been reported declining its effect on long-term observation (Matsunaga et al., 2009).”
BackgroundPosner, J., Marsh, R., Maia, T. V., Peterson, B. S., Gruber, A., & Simpson, H. B. (2014) · Human Brain Mapping · doi:10.1002/hbm.22371 · Cited by 197 · cited 2×
“The clinical and physiopathological phenotypes of OCD have been associated with cortico-striato-thalamo-cortical (CSTC) circuitries that subserve motivation and reward-aversion, emotional learning and goal-directed action (Ahmari et al., 2013; Anticevic et al., 2014; Burguiere et al., 2013; Dougherty et al., 2010; Mil…”
Background
Cited by
Fineberg, N. A., Hollander, E., Pallanti, S., Walitza, S., Grünblatt, E., Dell’Osso, B. M., Albert, U., Geller, D. A., Brakoulias, V., Janardhan Reddy, Y. C., et al. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000314 · Cited by 161
Self-citationLusicic, A., Schruers, K. R., Pallanti, S., & Castle, D. J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s121140 · Cited by 81
Self-citationGrassi, G., Makris, N., & Pallanti, S. (2020) · CNS Spectrums · doi:10.1017/s1092852919000993 · Cited by 35
Self-citationZou, J., Wu, S., Yuan, X., Hu, Z., Tang, J., & Hu, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.720518 · Cited by 13
Metadata
- Authors
- Pallanti, S., Marras, A., Salerno, L., Makris, N., & Hollander, E.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2016-02-03
- Volume
- 30
- Issue
- 6
- Pages
- 568-578
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2294728298
- Cited by
- 36
- References
- 13
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive–compulsive disorder, mini-review and pilot open-label trial. https://app.cochat.ai/papers/10.1177/0269881116628427
- The paper
- Pallanti, S., Marras, A., Salerno, L., Makris, N., & Hollander, E. (2016). Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive–compulsive disorder, mini-review and pilot open-label trial. Journal of Psychopharmacology. https://doi.org/10.1177/0269881116628427
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.